Furthermore, we provide in vivo evidence for the role of tumor-derived S100A4 in bone destruction and osteoclast formation by examining the effects of silencing the S100A4 gene and of a S100A4-blocking antibody (Ab) in a mouse xenograft model of breast cancer bone metastasis. This evidence concerns the gene S100A4 and breast carcinoma.